comparemela.com
Home
Live Updates
BioCryst Gains Drug Approval in Canada, Switzerland | North Carolina Biotechnology Center : comparemela.com
BioCryst Gains Drug Approval in Canada, Switzerland | North Carolina Biotechnology Center
A drug produced by BioCryst Pharmaceuticals of Durham has won regulatory approval in Canada and Switzerland for preventing hereditary angioedema (HAE), a rare disease of swollen tissues caused by excessive fluid buildup.
Related Keywords
United States
,
Canada
,
Dublin
,
Ireland
,
Switzerland
,
Canadians
,
Swiss
,
Canadian
,
Henrik Balle Boysen
,
Jared Rhines
,
Biocryst Pharmaceuticals Of Durham
,
Health Canada
,
Nasdaq
,
Biocryst Pharmaceuticals
,
comparemela.com © 2020. All Rights Reserved.